Statin use in patients with elevated serum hepatic transaminases at baseline: A meta-analysis
The objectives of this meta-analysis were to analyze the liver safety and cardiovascular benefit when using a statin-based lipid-lowering treatment compared to a less intensive treatment or placebo, in subjects with abnormal liver tests at baseline.
Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - Category: Nutrition Authors: Walter Masson, Mart ín Lobo, Gerardo Masson, Graciela Molinero, Paola Casciato Tags: Systematic Reviews and Meta-analyses Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Clinical Trials | Heart | Liver | Nutrition | Statin Therapy | Urology & Nephrology